Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125847551 | 12584755 | 1 | I | 20160707 | 20160722 | 20160722 | PER | US-CELGENEUS-USA-2016071787 | CELGENE | 0.00 | M | Y | 60.65000 | KG | 20160722 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125847551 | 12584755 | 1 | PS | THALOMID | THALIDOMIDE | 1 | Oral | U | B201103,B2005AC | 20785 | 150 | MG | CAPSULES | QD | |||||
| 125847551 | 12584755 | 2 | SS | THALOMID | THALIDOMIDE | 1 | Oral | 200-250MG | U | B201103,B2005AC | 20785 | CAPSULES | QD | ||||||
| 125847551 | 12584755 | 3 | SS | THALOMID | THALIDOMIDE | 1 | Oral | U | B201103,B2005AC | 20785 | 300 | MG | CAPSULES | QD | |||||
| 125847551 | 12584755 | 4 | SS | THALOMID | THALIDOMIDE | 1 | Oral | U | B201103,B2005AC | 20785 | 150 | MG | CAPSULES | QD | |||||
| 125847551 | 12584755 | 5 | SS | THALOMID | THALIDOMIDE | 1 | Oral | U | B201103,B2005AC | 20785 | 100 | MG | CAPSULES | QD | |||||
| 125847551 | 12584755 | 6 | C | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125847551 | 12584755 | 7 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125847551 | 12584755 | 8 | C | NEUPOGEN | FILGRASTIM | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125847551 | 12584755 | 9 | C | NEULASTA | PEGFILGRASTIM | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125847551 | 12584755 | 1 | Brain neoplasm malignant |
| 125847551 | 12584755 | 6 | Product used for unknown indication |
| 125847551 | 12584755 | 7 | Product used for unknown indication |
| 125847551 | 12584755 | 8 | Product used for unknown indication |
| 125847551 | 12584755 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125847551 | 12584755 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125847551 | 12584755 | Bone marrow failure | |
| 125847551 | 12584755 | Neuropathy peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125847551 | 12584755 | 1 | 20150504 | 0 | ||
| 125847551 | 12584755 | 2 | 201505 | 0 | ||
| 125847551 | 12584755 | 3 | 201508 | 0 | ||
| 125847551 | 12584755 | 4 | 20160119 | 0 | ||
| 125847551 | 12584755 | 5 | 201607 | 0 |